This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bicycletx Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Liudvikas Urbonas: Innovator in Bicyclic Peptide Ligands
Introduction
Liudvikas Urbonas is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, particularly in the development of peptide ligands. His work focuses on innovative solutions for therapeutic delivery systems.
Latest Patents
Liudvikas holds a patent for "Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)." This invention relates to polypeptides that are covalently bound to molecular scaffolds, allowing for the formation of peptide loops between attachment points. The peptides described in this patent are designed to bind to TfR1, which is crucial for the delivery of therapeutic agents. The invention also encompasses multimeric binding complexes that include these bicyclic peptide ligands, as well as pharmaceutical compositions that utilize them for treating various diseases through TfR1 mediated delivery.
Career Highlights
Liudvikas is associated with Bicycletx Limited, where he continues to advance his research and development efforts. His innovative approach has led to the creation of valuable intellectual property that can potentially transform therapeutic practices.
Collaborations
Liudvikas collaborates with talented individuals such as Ellen Gowans and Gemma Elizabeth Mudd. Their combined expertise enhances the research and development initiatives at Bicycletx Limited.
Conclusion
Liudvikas Urbonas is a pioneering inventor whose work on bicyclic peptide ligands has the potential to impact the field of medicine significantly. His contributions reflect a commitment to advancing therapeutic delivery systems and improving patient outcomes.